In addition, access to prevention and treatment services is limited in some parts of the world.
The
World Health Organization (WHO) estimates that, as a result, there were 1.7 million new infections with HIV in 2019, and 690,000 people died from HIV-related causes.
Despite decades of work, scientists have failed to develop an effective vaccine against the virus.
The reason for this is that most of the surface of the virus is densely coated with sugar molecules that do not trigger an immune response, and the parts that are exposed are highly variable.
As with SARS-CoV-2, which is the virus that causes COVID-19, HIV uses spike proteins on its outer surface to gain entry to its host cells.
Allogene Therapeutics and SpringWorks Therapeutics Announce Dosing of First Patient in Phase 1 Study Evaluating ALLO-715 in Combination with Nirogacestat in Patients with Relapsed or Refractory Multiple Myeloma forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
New test offers a simpler way to quantify the reservoir of intact viruses in HIV patients
A new test that measures the quantity and quality of inactive HIV viruses in the genes of people living with HIV may eventually give researchers a better idea of what drugs work best at curing the disease.
Currently no cure exists for HIV and AIDS, but antiretroviral therapy drugs, or ARTs, effectively suppress the virus to undetectable levels.
Published today in
Cell Reports Medicine, the study discusses how a new test, developed jointly by scientists at the University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, will give researchers, and eventually doctors, an easier way to gauge how much HIV virus might reside in a patient s genome.
A vaccine study in college students will help determine when it s safe to take masks off stripes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stripes.com Daily Mail and Mail on Sunday newspapers.
You got vaccinated. Now what? 7 things to know for your post-COVID vaccine behavior
April 10, 2021 at 8:38 am
The Centers for Disease Control and Prevention’s V-Safe tracks health status after a COVID-19 vaccination. (GeekWire Photo)
On April 15, anyone in Washington state who is 16 or older can roll up their sleeve and get a shot of COVID-19 vaccine. And once two weeks have passed after either one dose of the Johnson & Johnson vaccine, or a second dose of the Moderna or Pfizer vaccine, that person is now considered fully vaccinated.
And then what?
Vaccinated people can savor the fact that they are now almost certainly protected against getting seriously sick from COVID, let alone needing hospitalization or worse. They’re also contributing to herd immunity, a sought-after, community-wide resilience against the virus that will help shield people who cannot be vaccinated because they’re too young or have health conditions.